VYYRF - Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product License for SmoothX; Radiographic Barium Contrast Suspension
(TheNewswire)
Calgary, Alberta – TheNewswire - February 12, 2021 – Voyageur PharmaceuticalsLtd. ( TSXV : VM ) USA (OTC : VYYRF) (the "Company"or "Voyageur") is pleased to announcethat it has received approval from Health Canada for SmoothX. SmoothX is a barium radiographic contrast suspension that isspecifically formulated for computed tomography procedures (CT Scans). This approval authorizes the sale of SmoothX for use in radiologyprocedures in Canada. SmoothX is specifically designed for use onCT Scans of the abdomen and gastrointestinal tract in both adults andpediatric patients.
Voyageur has four additional barium radiographiccontrast Products that are currently under review by Health Canada andwe expect product licences to be forthcoming.
“Voyageur’s business plan has always been to launchBarium Contrast Radiographic Suspension products into the Canadianmarketplace initially, then pursue other markets. This approval is thecritical milestone to allow our company to transition to a cashflowing pharmaceutical company” reports Brent Willis, Voyageur’sCEO.
Voyageur has a strategic plan to advance through thestart-up phase of formulating, final testing of product and thenmanufacturing. This is expected to lead to full productionmanufacturing, sales and distribution of barium contrast productsnationally in the near term.
About Voyageur
Voyageur Pharmaceuticals Ltd. is Canadian publiccompany listed on the TSX Venture Exchange under the trading symbolVM. Voyageur is focused on the development of barite, iodine, andfullerene Active Pharmaceutical Ingredient (API) minerals. Thenear-term focus is developing barium, iodine radio-contrast productsand fullerene-based pharmaceutical products.
Voyageur’s goal is to initially generate the positivecash flow from operations using third party GMP pharmaceuticalmanufacturers in Canada and in India. Ultimately, Voyageur has plansto build all the required infrastructure to become 100%self-sufficient with all manufacturing.
Voyageur owns a 100% interest in three barium sulfate(barite) projects including two properties suitable in grade for theindustrial barite marketplace, with interests in a high-grade iodine,lithium & bromine brine project located in Utah, USA.
Voyageur is moving forward with its business plan ofbecoming the only fully integrated company in the radio-contrastmedical field, by controlling all primary input costs under the mottoof:
"From theEarth to the Bottle"
www.voyageurpharmaceuticals.ca
For Further Media Information or toset up an interview, please contact:
Brent Willis
President & CEO
Ron Love
CFO
T 403.818.6086
Forward Looking Information
This news release may contain certainforward-looking information and statements, including withoutlimitation, statements pertaining to timing for manufacturing andsales of SmoothX and the Company's ability to obtain necessaryapprovals from Health Canada for the four additional bariumradiographic contrast products. All statements included herein, otherthan statements of historical fact, are forward-looking informationand such information involves various risks and uncertainties. Therecan be no assurance that such information will prove to be accurate,and actual results and future events could differ materially fromthose anticipated in such information. A description of assumptionsused to develop such forward-looking information and a description ofrisk factors that may cause actual results to differ materially fromforward-looking information can be found in the Company's disclosuredocuments on the SEDAR website at www.sedar.com . Voyageur does not undertake to updateany forward-looking information except in accordance with applicablesecurities laws.
Reader Advisory
Neither the TSXV nor its RegulationServices Provider (as that term is defined in the policies of theTSXV) accepts responsibility for the adequacy or accuracy of this newsrelease.
NOT FOR DISTRIBUTION TO THE U.S.NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Copyright (c) 2021 TheNewswire - All rights reserved.